MINERVA SURGICAL INC Quarterly Selling and Marketing Expense in USD from Q3 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Minerva Surgical Inc quarterly/annual Selling and Marketing Expense history and growth rate from Q3 2020 to Q3 2023.
  • Minerva Surgical Inc Selling and Marketing Expense for the quarter ending September 30, 2023 was $6.71M, a 31% decline year-over-year.
  • Minerva Surgical Inc Selling and Marketing Expense for the twelve months ending September 30, 2023 was $35.7M, a 6.49% decline year-over-year.
  • Minerva Surgical Inc annual Selling and Marketing Expense for 2022 was $38.3M, a 19.1% increase from 2021.
  • Minerva Surgical Inc annual Selling and Marketing Expense for 2021 was $32.2M, a 40.1% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $35.7M $6.71M -$3.01M -31% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $38.7M $9.36M -$330K -3.41% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $39.1M $10.2M +$729K +7.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $38.3M $9.44M +$133K +1.43% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-22
Q3 2022 $38.2M $9.72M +$1.8M +22.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $36.4M $9.69M +$1.19M +14.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $35.2M $9.47M +$3M +46.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $32.2M $9.31M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $7.92M +$1.2M +17.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $8.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $6.47M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $6.72M Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.